Keywords: ec, oks, new, dosage, strengths, gsk, avandamet

EC OKs new dosage strengths of GSK's Avandamet

Article | 20 September 2004

Print This

UK drug major GlaxoSmithKline says the European Commission hasapproved two new dosage strengths of its Avandamet, a treatment for type 2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in